Sequence variants in host cell factor C1 are associated with mániàre's disease

Otology and Neurotology

Volumn 29, Issue 4, 2008, Pages 561-566

  Vrabec, Jeffrey T ^a,b   Liu, Liqian ^a   Li, Bingshan ^b   Leal, Suzanne M ^b  

^a Bobby R Alford Department of Otolaryngology Head and Neck Surgery   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Herpes simplex virus; Host cell factor C1; M ni re's disease

Indexed keywords

HOST CELL FACTOR C1; DNA; HCFC1 PROTEIN, HUMAN;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MENIERE DISEASE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; EXON; GENETICS; GENOTYPE; INTRON; ISOLATION AND PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK; STATISTICAL ANALYSIS;

DATA INTERPRETATION, STATISTICAL; DNA; EXONS; GENOTYPE; HOST CELL FACTOR C1; HUMANS; INTRONS; MENIERE DISEASE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VARIATION (GENETICS);

EID: 47249119155     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318168d23b     Document Type: Article

References (31)

1. Wladislavosky-Waserman P, Facer GW, Mokri B, Kurland LT. Ménière's disease: a 30-year epidemiologic and clinical study in Rochester, Mn, 1951-1980. Laryngoscope 1984;94:1098-102.
2. Brown MR. Ménière's syndrome. Arch Neurol Psychiatry 1941; 46:561-5.
3. Morrison AW. Ménière's disease. J Laryng Otol 1995;109: 499-502.
4. Morrison AW, Johnson KJ. Ménière's disease. Otolaryngol Clin North Am 2002;35:497-516.
5. Birgerson L, Gustavson KH, Stahle J. Ménière's disease: a genetic investigation. Am J Otol 1987;8:323-6.
6. Fung K, XieY, Hall SF, Lillicrap DP, Taylor SA. Ménière's disease. J Otolaryngol 2002;31:1-4.
7. Oliveira CA, Ferrari I, Messias CI. Ménière's syndrome and migraine in Brasilia. Ann Otol Rhinol Laryngol 2002;111:229-36.
8. Ruckenstein MJ, Prasthoffer A, Bigelow DC, Von Feldt JM, Kolasinski SL. Ménière's disease. Otol Neurotol 2002;23:517-20.
9. Fransen E, Verstreken M, Verhagen WIM, et al. Ménière's disease in three families with a mutation in the COCH gene. Hum Molec Genet 1999;8:1425-9.
10. Usami S, Takahashi K,Yuge I, et al. Mutations in the COCH gene are a frequent cause of autosomal dominant progressive cochleo-vestibular dysfunction, but not of Ménière's disease. Eur J Hum Genet 2003;11:744-8.
11. Mhatre AN, Jero J, Chiappini I, Bolasco G, Barbara M, Lalwani AK. Aquaporin-2 expression in the mammalian cochlea and investigation of its role in Ménière's disease. Hear Res 2002; 170:59-69.
12. Doi K, Sato T, Kuramasu T, et al. Ménière's disease is associated with single nucleotide polymorphisms in the human potassium channel genes, KCNE1 and KCNE3. ORL J Otorhinolaryngol Relat Spec 2005;67:289-93.
13. Klar J, Frykholm C, Friberg U, Dahl N. A Ménière's disease gene linked to chromosome 12p12.3. Am J Med Genet B Neuropsychiatr Genet 2006;141:463-7.
14. Ruckenstein MJ, Rutka JA, Hawke M. Ménière's disease: Torok revisited. Laryngoscope 1991;101:211-8.
15. Grant IL, Welling DB. Ménière's disease. Otolaryngol Clin North Am 1997;30:1123-44.
16. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
17. Merchant SN, Rauch SD, Nadol JB Jr. Ménière's disease. Eur Arch Otorhinolaryngol 1995;252:63-75.
18. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003;25:115-21.
19. Zoppe M, Frattini A, Faranda S, Vezzoni P. The complete sequence of the host cell factor 1 (HCFC1) gene and its promoter: a role forYY1 transcription factor in the regulation of its expression. Genomics 1996;34:85-91.
20. Wilson AC, Lamarco K, Peterson MG, Herr W. The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein. Cell 1993;74:115-25.
21. Khurana B, Kristie TM. A protein sequestering system reveals control of cellular programs by the transcriptional coactivator HCF-1. J Biol Chem 2004;279:33673-83.
22. Wilson AC, Parrish JE, Massa HF, Nelson DL, Trask BJ, Herr W. The gene encoding the VP16-accessory protein HCF (HCFC1) resides in human Xq28 and is highly expressed in fetal tissues and the adult kidney. Genomics 1995;25:462-8.
23. Kristie TM, Vogel JL, Sears AE. Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc Natl Acad Sci U S A 1999;96:1229-33.
24. Wysocka J, Herr W. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem Sci 2003;28:294-304.
25. Narayanan A, Nogueira ML, Ruyechan WT, Kristie TM. Combinatorial transcription of herpes simplex virus and varicella zoster virus immediate early genes is strictly determined by the cellular coactivator HCF-1. J Biol Chem 2005;280:1369-75
26. Johnson KM, Mahajan SS, Wilson AC. Herpes simplex virus trans-activator VP16 discriminates between HCF-1 and a novel family member, HCF-2. J Virol 1999;73:3930-40.
27. Mahajan SS, Wilson AC. Mutations in host cell factor 1 separate its role in cell proliferation from recruitment of VP16 and LZIP. Mol Cell Biol 2000;20:919-28.
28. Goto H, Motomura S, Wilson AC, Freiman RN, NakabeppuY, Fukushima K, et al. A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function. Genes Dev 1997;11:726-37.
29. Freiman RN, Herr W. Viral mimicry: common mode of association with HCF by VP16 and the cellular protein LZIP. Genes Dev 1997;11:3122-7.
30. Vrabec JT. Ménière's disease. Laryngoscope 2003;113:1431-8.
31. Vrabec JT, Alford RL. Quantitative analysis of herpes simplex virus in cranial nerve ganglia J Neurovirol 2004;10:216-22.